QuantumCell
A quarter of billion-euro licences, a Novo comeback and a flat Nordic index – the State of Nordic BioPharma | 2026:Q3
Analytics
Demant raises the bar, XVIVO clears hearts and Zealand cashes in – the Nordic Pulse | 2026:33
Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27
Analytics
